Pure Global

Eye-tracking brain injury assessment device

Access comprehensive regulatory information for Eye-tracking brain injury assessment device in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by TBI diagnostics Pty Ltd, manufactured by Oculogia Inc in United States of America. The device registration started on April 19, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Eye-tracking brain injury assessment device
Australia TGA ARTG Registered Device
Good Name: TBI diagnostics Pty Ltd - Eye-tracking brain injury assessment device
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The EyeBOX is intended to measure and analyze eye movements as an aid in the diagnosis of concussion within one week of head injury in patients 5 through 67 years of age in conjunction with a standard neurological assessment of concussion. A negative EyeBOX classification may correspond to eye movement that is consistent with a lack of concussion. A positive EyeBOX classification corresponds to eye movement that may be present in both patients with or without concussion.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
April 19, 2021
Effective Date
April 19, 2021
Manufacturer
Country
United States of America
Address
33 Irving Place, New York, New York, 10003